Engineered gut bacteria helped activate immune attacks against pancreatic tumors in animal models. Many solid tumors, including pancreatic tumors, contain regions with little oxygen, while healthy tissues generally contain enough oxygen to restrict the bacterium’s growth. Combination treatments improve tumor controlIn animal experiments, BifidoSumIL-2 accumulated selectively inside tumors, stimulated immune activity and slowed the growth of pancreatic cancer. It also altered the tumor microenvironment by increasing the activity of CD8+ T cells, which can recognize and destroy cancer cells. Researchers also want to test the approach alongside newer pancreatic cancer treatments, including KRAS inhibitors.